{"AAP": {"Ticker": "AAP", "Company": "Advance Auto Parts", "Sector": "Consumer Discretionary", "Updated": "2023-03-31", "Rating": [{"Date": "2023-03-31", "Rating": "Upgrade", "Organization": "Barclays", "Rating_Change": "Underweight to Equal Weight", "Target_Change": "$140 to $129"}, {"Date": "2023-03-13", "Rating": "Downgrade", "Organization": "Argus", "Rating_Change": "Buy to Hold", "Target_Change": ""}, {"Date": "2023-02-13", "Rating": "Downgrade", "Organization": "ROTH MKM", "Rating_Change": "Buy to Neutral", "Target_Change": "$180 to $140"}, {"Date": "2023-02-08", "Rating": "Initiated", "Organization": "Barclays", "Rating_Change": "Underweight", "Target_Change": "$145"}, {"Date": "2023-01-12", "Rating": "Downgrade", "Organization": "Wedbush", "Rating_Change": "Outperform to Neutral", "Target_Change": "$145"}], "Score": -0.6, "Cumulative_Rating": "Underperform", "Number_of_Analysts": 5, "Period": "180 days", "Letter_Rating": "D", "Analists": ["Argus", "ROTH MKM", "Barclays", "Wedbush"], "Price_Target": 139.75}, "ABC": {"Ticker": "ABC", "Company": "AmerisourceBergen", "Sector": "Health Care", "Updated": "2023-03-31", "Rating": [{"Date": "2023-03-31", "Rating": "Initiated", "Organization": "Citigroup", "Rating_Change": "Buy", "Target_Change": "$185"}, {"Date": "2023-01-31", "Rating": "Resumed", "Organization": "Evercore ISI", "Rating_Change": "Outperform", "Target_Change": "$185"}], "Score": 2.0, "Cumulative_Rating": "Significant Outperform", "Number_of_Analysts": 2, "Period": "180 days", "Letter_Rating": "A", "Analists": ["Citigroup", "Evercore ISI"], "Price_Target": 185.0}, "CAH": {"Ticker": "CAH", "Company": "Cardinal Health", "Sector": "Health Care", "Updated": "2023-03-31", "Rating": [{"Date": "2023-03-31", "Rating": "Initiated", "Organization": "Citigroup", "Rating_Change": "Neutral", "Target_Change": "$77"}, {"Date": "2023-02-03", "Rating": "Upgrade", "Organization": "Robert W. Baird", "Rating_Change": "Neutral to Outperform", "Target_Change": "$87 to $94"}], "Score": 1.0, "Cumulative_Rating": "Outperform", "Number_of_Analysts": 2, "Period": "180 days", "Letter_Rating": "B", "Analists": ["Robert W. Baird", "Citigroup"], "Price_Target": 85.5}, "CTAS": {"Ticker": "CTAS", "Company": "Cintas Corporation", "Sector": "Industrials", "Updated": "2023-03-31", "Rating": [{"Date": "2023-03-31", "Rating": "Downgrade", "Organization": "Jefferies", "Rating_Change": "Buy to Hold", "Target_Change": "$512 to $487"}], "Score": -1.0, "Cumulative_Rating": "Underperform", "Number_of_Analysts": 1, "Period": "180 days", "Letter_Rating": "D", "Analists": ["Jefferies"], "Price_Target": 487.0}, "GNRC": {"Ticker": "GNRC", "Company": "Generac Holdings", "Sector": "Industrials", "Updated": "2023-03-31", "Rating": [{"Date": "2023-03-31", "Rating": "Downgrade", "Organization": "BofA Securities", "Rating_Change": "Neutral to Underperform", "Target_Change": "$141 to $91"}, {"Date": "2023-03-10", "Rating": "Downgrade", "Organization": "Citigroup", "Rating_Change": "Buy to Neutral", "Target_Change": "$380 to $140"}, {"Date": "2023-03-02", "Rating": "Initiated", "Organization": "Scotiabank", "Rating_Change": "Sector Perform", "Target_Change": "$165"}, {"Date": "2023-02-21", "Rating": "Downgrade", "Organization": "Truist", "Rating_Change": "Buy to Hold", "Target_Change": "$145"}, {"Date": "2023-02-17", "Rating": "Downgrade", "Organization": "Wells Fargo", "Rating_Change": "Overweight to Equal Weight", "Target_Change": "$135"}, {"Date": "2023-02-16", "Rating": "Upgrade", "Organization": "Canaccord Genuity", "Rating_Change": "Hold to Buy", "Target_Change": "$104 to $175"}, {"Date": "2023-02-03", "Rating": "Downgrade", "Organization": "Guggenheim", "Rating_Change": "Buy to Neutral", "Target_Change": ""}], "Score": -0.86, "Cumulative_Rating": "Underperform", "Number_of_Analysts": 7, "Period": "180 days", "Letter_Rating": "D", "Analists": ["BofA Securities", "Truist", "Wells Fargo", "Canaccord Genuity", "Guggenheim", "Scotiabank", "Citigroup"], "Price_Target": 141.83}, "PEAK": {"Ticker": "PEAK", "Company": "Healthpeak Properties", "Sector": "Real Estate", "Updated": "2023-03-31", "Rating": [{"Date": "2023-03-31", "Rating": "Downgrade", "Organization": "Scotiabank", "Rating_Change": "Sector Outperform to Sector Perform", "Target_Change": "$24"}, {"Date": "2023-01-03", "Rating": "Upgrade", "Organization": "Jefferies", "Rating_Change": "Hold to Buy", "Target_Change": "$23 to $29"}], "Score": -0.5, "Cumulative_Rating": "Neutral", "Number_of_Analysts": 2, "Period": "180 days", "Letter_Rating": "C", "Analists": ["Jefferies", "Scotiabank"], "Price_Target": 26.5}, "HWM": {"Ticker": "HWM", "Company": "Howmet Aerospace", "Sector": "Industrials", "Updated": "2023-03-31", "Rating": [{"Date": "2023-03-31", "Rating": "Upgrade", "Organization": "The Benchmark Company", "Rating_Change": "Hold to Buy", "Target_Change": "$49"}, {"Date": "2023-03-22", "Rating": "Initiated", "Organization": "Jefferies", "Rating_Change": "Buy", "Target_Change": "$50"}, {"Date": "2023-02-15", "Rating": "Downgrade", "Organization": "The Benchmark Company", "Rating_Change": "Buy to Hold", "Target_Change": ""}], "Score": 0.67, "Cumulative_Rating": "Outperform", "Number_of_Analysts": 3, "Period": "180 days", "Letter_Rating": "B", "Analists": ["Jefferies", "The Benchmark Company"], "Price_Target": 49.5}, "MCK": {"Ticker": "MCK", "Company": "McKesson Corporation", "Sector": "Health Care", "Updated": "2023-03-31", "Rating": [{"Date": "2023-03-31", "Rating": "Initiated", "Organization": "Citigroup", "Rating_Change": "Buy", "Target_Change": "$420"}], "Score": 2.0, "Cumulative_Rating": "Significant Outperform", "Number_of_Analysts": 1, "Period": "180 days", "Letter_Rating": "A", "Analists": ["Citigroup"], "Price_Target": 420.0}, "ZBH": {"Ticker": "ZBH", "Company": "Zimmer Biomet", "Sector": "Health Care", "Updated": "2023-03-31", "Rating": [{"Date": "2023-03-31", "Rating": "Upgrade", "Organization": "Jefferies", "Rating_Change": "Underperform to Hold", "Target_Change": "$115 to $130"}, {"Date": "2023-03-29", "Rating": "Initiated", "Organization": "UBS", "Rating_Change": "Sell", "Target_Change": "$112"}, {"Date": "2023-03-10", "Rating": "Upgrade", "Organization": "Piper Sandler", "Rating_Change": "Neutral to Overweight", "Target_Change": "$135 to $145"}, {"Date": "2023-01-09", "Rating": "Upgrade", "Organization": "RBC Capital Mkts", "Rating_Change": "Sector Perform to Outperform", "Target_Change": "$125 to $141"}, {"Date": "2023-01-05", "Rating": "Upgrade", "Organization": "Raymond James", "Rating_Change": "Mkt Perform to Outperform", "Target_Change": "$144"}, {"Date": "2023-01-03", "Rating": "Downgrade", "Organization": "Evercore ISI", "Rating_Change": "Outperform to In-line", "Target_Change": "$130"}], "Score": 0.33, "Cumulative_Rating": "Neutral", "Number_of_Analysts": 6, "Period": "180 days", "Letter_Rating": "C", "Analists": ["RBC Capital Mkts", "Raymond James", "Piper Sandler", "Jefferies", "Evercore ISI", "UBS"], "Price_Target": 133.67}}